Eric Xiao
About Eric Xiao
Eric Xiao serves as the Senior Director of Corporate Affairs at ElevateBio, having previously held various roles in corporate governance and research across multiple organizations, including Bardavon Health Innovations and Matrix Capital Management.
Current Role at ElevateBio
Eric Xiao serves as the Senior Director of Corporate Affairs at ElevateBio. He has held this position since 2024, contributing to the company's strategic initiatives and corporate communications. His role involves overseeing corporate affairs, which includes managing stakeholder relationships and enhancing the company's public image.
Previous Experience at Bardavon Health Innovations
Prior to his current role, Eric Xiao worked at Bardavon Health Innovations in multiple capacities. He served as General Manager for Injury Prevention and Head of Corporate Development from 2023 to 2024. Additionally, he was a Board Observer for Bardavon from 2021 to 2022 and held the position of Head of Corporate Development in 2022.
Experience in Financial Management at Matrix Capital Management
Eric Xiao has extensive experience in financial management through his tenure at Matrix Capital Management Company, L.P. He worked there as an Associate from 2018 to 2020, then progressed to the role of Vice President from 2020 to 2021, and later served as Principal from 2021 to 2022. His roles involved investment analysis and portfolio management in the Greater Boston Area.
Research Background at Yale University
Eric Xiao's academic background includes significant research experience at Yale University. He worked as an Undergraduate Researcher in the Department of Molecular, Cellular and Developmental Biology from 2013 to 2016. He also held the position of Student Administrator, Researcher, and Archivist in the same department from 2014 to 2016. His research contributions were under the guidance of Dr. Valerie Horsley.
Educational Qualifications from Yale University
Eric Xiao earned his Bachelor’s Degree from Yale University, where he studied Political Science and Pre-Medical Studies from 2012 to 2016. His education provided a strong foundation for his subsequent roles in corporate affairs and management.